Rythmologie et stimulation (partie I)

Vendredi 16 Janvier 2015   09:00-18:00   Espace posters
Posters par thème
Clinical interest of transesophageal electrophysiological study in patients with no documented tachycardia suspected of paroxysmal supraventricular tachycardia
09:00 • Patrick Dary
Telemonitoring for arrhythmias on rural outpatients: feasibility and results on 167 patients
09:00 • Peggy Jacon
Contributions of remote monitoring to the follow-up of implantable loop recorders : a dual center experience
09:00 • Sok-Sithikun Bun
Non-contrast cardiac resynchronization therapy implantation is feasible in case of renal insufficiency
09:00 • Walid Amara
Strategy of early detection and active management of supraventricular arrhythmia with remote monitoring: The randomized, multicenter SETAM trial
09:00 • Jérôme Taieb
Strategy of anticoagulation in pacemaker and ICD replacement procedure in real life. The French Electra survey
09:00 • Karine Bauley
Comparison of transvenous versus surgical implantation of left ventricular lead for cardiac resynchronization therapy
09:00 • Dorothée Ardourel
Repeated external electrical cardioversion after a first unsuccessful attempt in persistent atrial fibrillation.
Circadian behavior of RR ventricular tachycardia cycle length stability in heart failure ICD recipients.
09:00 • Elodie Lematte
Prevalence and prognosis role of wide QRS and of QRS narrower than normal
09:00 • Hager Rekik
Transvenous extraction of pacing and defibrillator leads: a high-volumesingle centre experience
09:00 • Rim El Bouazzaoui
Anticoagulation therapy is frequent in patients with silent AF detected in cardiac devices memory, despite an absence of current guidelines : a monocentric registry
09:00 • Philippe Mabo
Septal right ventricular lead positioning and optimized DDD pacing versus intrinsic conduction in sinus node disease: an echocardiographic study. The Optimist trial
Initiation of the cardiac stimulation in sub-saharan Africa, case of the university hospital of brazzaville: indications and obstacles
Malignant response to Ajmaline challenge in SCN5A mutation carriers: experience from a large familial study